SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SATT South East SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11246
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology consulting and licensing services. It also manages the portfolios of intellectual property of several organizations. The company offers services in areas of digital and connected information society, health and life technologies; environment, energy and territories, industrial processing, and culture, heritage and digital humanities. It serves materials, environment and information technologies such as hardware and embedded, multimedia, data processing, software engineering, chemistry process, material and mechanical engineering, energy, optical, environment and other sectors. SATT South East is headquartered in Marseille, France.

SATT South East SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SATT South East SAS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Licensing Agreements 13
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS – Key Competitors 18
SATT South East SAS – Key Employees 19
SATT South East SAS – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
SATT South East SAS, Pharmaceuticals & Healthcare, Key Facts 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS, Key Competitors 18
SATT South East SAS, Key Employees 19

List of Figures
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Fluor Corporation:戦略・SWOT・企業財務分析
    Fluor Corporation - Strategy, SWOT and Corporate Finance Report Summary Fluor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • U.S. Bancorp:企業の戦略・SWOT・財務情報
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Corium International Inc (CORI):医療機器:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Nuri Telecom Co., Ltd. (040160):企業の財務・戦略的SWOT分析
    Nuri Telecom Co., Ltd. (040160) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Relief Therapeutics Holding AG (RLF):製薬・医療:M&Aディール及び事業提携情報
    Summary Relief Therapeutics Holding AG (Relief Therapeutics) is a drug development company that offers clinical development of peptides and proteins of natural or engineered origin. The company’s pipeline drug candidates include aviptadil for the treatment of sarcoidosis and low dose interleukin-6 t …
  • Weatherford International plc:企業の戦略・SWOT・財務情報
    Weatherford International plc - Strategy, SWOT and Corporate Finance Report Summary Weatherford International plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ZIOPHARM Oncology Inc (ZIOP):製薬・医療:M&Aディール及び事業提携情報
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc, is a next-generation immune therapies provider. The company offers controlled IL-12 and t-cell therapy. Its next-generation immune therapie platform provides turning cold tumors hot by activating an immune response and non viral genetic …
  • BioStar Pharmaceuticals Inc (BSPM):企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Shenzhen Century Plaza Hotel Co., Ltd.:企業の戦略・SWOT・財務情報
    Shenzhen Century Plaza Hotel Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shenzhen Century Plaza Hotel Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Acea SpA (ACE):企業の財務・戦略的SWOT分析
    Acea SpA (ACE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Caprion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Caprion Biosciences Inc (Caprion) is a provider of proteomics and immune monitoring services. The company provides proteomic based services such as neo-epitope discovery and characterization, biomarker discovery, fit-for-purpose assays, host cell protein detection, PK assays, and others. It …
  • Bilfinger SE:企業のM&A・事業提携・投資動向
    Bilfinger SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bilfinger SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • CytomX Therapeutics Inc (CTMX):企業の財務・戦略的SWOT分析
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • Kodiak Sciences Inc (KOD):製薬・医療:M&Aディール及び事業提携情報
    Summary Kodiak Sciences Inc (Kodiak Sciences), formerly Oligasis LLC is a drug development company that discovers new medicines for the healthcare sector. The company provides retinal medicines for treatment of wet and dry forms of age-related macular degeneration. It utilizes proprietary Bioconjuga …
  • California Pizza Kitchen, Inc.:企業の戦略・SWOT・財務分析
    California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report Summary California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tat Seng Packaging Group Ltd. (T12):企業の戦略的SWOT分析
    Tat Seng Packaging Group Ltd. (T12) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆